Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization

Documenti analoghi

• Vaccination with the Recombinant Major Outer Membrane Protein Elicits Antibodies to the Constant Domains and Induces Cross-Serovar Protection against Intranasal Challenge with Chlamydia trachomatis
  di: Tifrea, Delia F., et al.
  Pubblicazione: (2013)
• A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility
  di: Tifrea, Delia F, et al.
  Pubblicazione: (2020)
• Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine
  di: Carmichael, Jennifer R., et al.
  Pubblicazione: (2011)
• Protection of outbred mice against a vaginal challenge by a Chlamydia trachomatis serovar E recombinant major outer membrane protein vaccine is dependent on phosphate substitution in the adjuvant
  di: Pal, Sukumar, et al.
  Pubblicazione: (2020)
• A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors
  di: Cheng, Chunmei, et al.
  Pubblicazione: (2011)